ImmunoGen, Inc. (IMGN) — Analyst outlook / Analyst consensus target is. Based on 22 analyst ratings, the consensus is bullish — 6 Buy, 15 Hold, 1 Sell.
The consensus price target is $14.79 (low: $6.36, high: $22.00), representing a downside of 52.6% from the current price $31.24.
IMGN Stock — 12-Month Price Forecast
$14.79
▼ -52.65% Downside
Average Price Target
Based on 22 Wall Street analysts offering 12-month price targets for ImmunoGen, Inc., the average price target is $14.79, with a high forecast of $22.00, and a low forecast of $6.36.
The average price target represents a -52.65% change from the last price of $31.24.
Highest Price Target
$22.00
Average Price Target
$14.79
Lowest Price Target
$6.36
IMGN Analyst Ratings
Hold
Based on 22 analysts giving stock ratings to ImmunoGen, Inc. in the past 3 months
